A rare event of 5-fluorouracil - Associated peripheral neuropathy: A report of two patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 3, 1998, Pages 248-249

  Stein, M E ^a   Drumea, K ^a   Yarnitsky, D ^a   Benny, A ^a   Tzuk Shina, T ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

5 Fluorouracil; Peripheral neuropathy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER CLASSIFICATION; CASE REPORT; CLINICAL FEATURE; DEMYELINATION; DISEASE ASSOCIATION; DOSE RESPONSE; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; PERIPHERAL NEUROPATHY; TREATMENT INDICATION; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DEMYELINATING DISEASES; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS;

EID: 0031812193     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199806000-00008     Document Type: Article

References (8)

1. Allegra CJ, Grem JL. Antimetabolites. In: De Vita V Jr, Hellman S, Rosenberg SA, eds. Cancer - Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997:432-52.
2. Moertel CG, Fleming TR, MacDonald JS, et al. Levamisol and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
3. Di Trapani G, Carnevale A, Cioffi RP, et al. Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol 1996;15:135-8.
4. Sarova-Pinhas I, Achiron A, Gilad R, Lampl Y. Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Acta Neurol Scand 1995;91:234-8.
5. Milano G, Etienne MC, Cassuto-Viguier E, et al. Influence of sex and age on fluorouracil clearance. J Clin Oncol 1992; 10:1171-5.
6. Saletti P, Pagani O, Sessa C, et al. Two cases of neurotoxicity possibly related to 5-fluorouracil and FA administration. Ann Oncol 1996;7:213-4.
7. Hook CC, Kimmel DW, Kvols, et al. Multifocal inflammatory leuko-encephalopathy with 5-Fluorouracil and levamisol. Ann Neurol 1992;31:262-7.
8. Bixenman WW, Nicholls JV, Warwick OH. Oculomotor disturbances associated with 5-fluorouracil chemotherapy. Am J Ophthalmol 1977;83:789-93.